News Conference News ACC 2025 Cardiologists Plot Next Moves After New Board Rejected Yael L. Maxwell April 11, 2025
News Conference News ACC 2025 RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up Michael O'Riordan April 08, 2025
News Conference News ACC 2025 AI Shows Promise in Detecting Type 1 MI and Need for Revascularization Yael L. Maxwell April 07, 2025
News Conference News ACC 2025 DETECT-AS: Alert System Increases AV Replacement in Eligible Patients Michael O'Riordan April 04, 2025
News Conference News ACC 2025 Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP Michael O'Riordan April 01, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE Michael O'Riordan March 31, 2025
News Conference News ACC 2025 Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years L.A. McKeown March 30, 2025
News Conference News ACC 2025 Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI Caitlin E. Cox March 30, 2025
News Conference News ACC 2025 Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection Michael O'Riordan March 30, 2025
News Conference News ACC 2025 SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes Michael O'Riordan March 29, 2025
News Daily News ACC 2025 STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients L.A. McKeown March 29, 2025
News Conference News ACC 2025 WARRIOR: No Clear Answers on How to Best Treat INOCA Yael L. Maxwell March 29, 2025
News Opinion Editor's Corner ACC 2025 What’s Going to Be Hot at ACC 2025? Michael O'Riordan March 26, 2025
News Conference News ACC 2024 IMPROVE-HCM: Ninerafaxstat May Fill a Niche in Nonobstructive HCM Caitlin E. Cox April 15, 2024
News Conference News ACC 2024 HUDDLE Up! High BP and Cardiac Changes Prevalent in Retired NFL Players Michael O'Riordan April 15, 2024
News Conference News ACC 2024 Telemedicine Strategy After MI Scores a Win in TELE-ACS Caitlin E. Cox April 12, 2024
News Conference News ACC 2024 Vaping Linked to Higher Risk of HFpEF, NIH Data Show L.A. McKeown April 12, 2024
News Conference News ACC 2024 Need a Statin for Primary Prevention? There’s an App for That Michael O'Riordan April 10, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Conference News ACC 2024 Another Win for TAVI in Patients at Low-to-Intermediate Risk: DEDICATE-DZHK6 Yael L. Maxwell April 08, 2024